Meiyue Dong

Meiyue Dong

Auto-generated profile, based on publicly available information

Meiyue Dong

Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Science Advances
Verified
Journal Article
Open access
IGIrina N. Gaisina
Irina N. Gaisina
PLPing Li
Ping Li
RDRuikun Du
Ruikun Du
QCQINGHUA CUI
QINGHUA CUI
MDMeiyue Dong
Meiyue Dong
Lijun RongLijun Rong
Lijun Rong
Seasonal or pandemic illness caused by influenza A viruses (IAVs) is a major public health concern due to the high morbidity and notable mortality. Although there are several approved drugs targeting different mechanisms, the emergence of drug resistance calls for new drug candidates that can be used alone or in combinations. Small-molecule IAV entry inhibitor, ING-1466, binds to hemagglutinin (HA) and blocks HA-mediated viral infection. Here, we show that this inhibitor demonstrates preventive and therapeutic effects in a mouse model of IAV with substantial improvement in the survival rate. When administered orally it elicits a therapeutic effect in mice, even after the well-established infection. Moreover, the combination of ING-1466 with oseltamivir phosphate or baloxavir marboxil enhances the therapeutic effect in a synergistic manner. Overall, ING-1466 has excellent oral bioavailability and in vitro absorption, distribution, metabolism, excretion, and toxicity profile, suggesting that it can be developed for monotherapy or combination therapy for the treatment of IAV infections.

1 January 2022 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
MDMeiyue Dong
Meiyue Dong
HDHaitao Du
Haitao Du
XLXueling Li
Xueling Li
LZLing Zhang
Ling Zhang
XWXiaoming Wang
Xiaoming Wang
Haiqiang JiangHaiqiang Jiang
Haiqiang Jiang
Background: Agarwood, as a traditional Chinese medicine, has great potential value for the treatment of tranquilization. However, its potential mechanisms and biomarkers are still unclear. Methods: In this study, ultra-high performance liquid chromatography-quadrupole-Exactive Orbitrap mass spectrometry (UHPLC-Q-Exactive Orbitrap-MS)-based metabonomics was adopted to discover the potential biomarkers in mice after agarwood incense smoke (AIS) intervention. Furthermore, the chemical components in agarwood were identified based on UHPLC-Q-Exactive Orbitrap-MS. The global view of potential compound-target-pathway (C-T-B) network was constructed through network pharmacology to understand the potentially material basis of biomarkers. Results: Metabolic profiling indicated that the metabolic changed significantly in mice serum after AIS intervention. A total of 18 potential biomarkers closely related to insomnia and emotional disease were identified, mainly involving in tryptophan metabolism, arginine and proline metabolism, cysteine and methionine metabolism and steroid hormone biosynthesis pathways. A total of 138 components in agarwood were identified based on UHPLC-Q-Exactive Orbitrap-MS. The results showed that mainly compounds such as flidersia type 2-(2-phenylethyl) chromones (FTPECs) and sesquiterpenes exerted good docking abilities with key target proteins, which were involved in multiple diseases including depression and hypnosis. Conclusion: In conclusion, this study enhanced current understanding of the change of metabolic markers after AIS intervention. Meanwhile, it also confirmed the feasibility of combining metabolomics and network pharmacology to identify active components and elucidate the material basis of biomarkers and mechanisms.

5 March 2023 in Journal of Medical Virology
Verified
Journal Article
Closed access
ZCZinuo Chen
Zinuo Chen
RDRuikun Du
Ruikun Du
LCLaura Cooper
Laura Cooper
JAJazmin Galván Achi
Jazmin Galván Achi
MDMeiyue Dong
Meiyue Dong
QCQinghua Cui
Qinghua Cui